Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 51662-1370

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage 1 (Dosage 1)

This is a set of recommended dosages for different authors for a medication administered intravenously. Dosages vary from a constant infusion over 24 hours after an initial injection to a single injection of 1-6 mg/kg of body weight.*

FDA Label Image

Dosage 2 (Dosage 2)

This appears to be a table that provides recommended dosages of Dexamethasone Phosphate (in milligrams) for different types of injection sites, including large joints (e.g., knee), small joints (e.g., Temporomandibular), bursae, tendon sheaths, soft tissue infiltration, and ganglia.*

FDA Label Image

How Suplied (How Supplied)

The given text provides information about Dexamethasone Sodium Phosphate Injection, USP which is available in three different types of packagings based on the volume of fill and the dosage strength. These packages are in the form of flip-top vials and are numbered as 16501, 16505 and 16530 with NDC codes 63323-165-. The details of the volume, dosage strength, and packaging quantity of each of the three variants are provided in the text.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

This document contains information about a pharmaceutical product called Jexamethasone, which is meant for intravenous use. The product is supplied in a multiple dose vial, containing 5mL of solution. The vial may be used for routes of administration other than intravenous, however further instructions should be sought for such use. The document also contains a unique product number (01)00351662137017 and a manufacture date of 17th November 2011.*

FDA Label Image

Structure (Structure)

The text appears to be a chemical formula description for two compounds: one is CH,0PO(ONa) and the other is C,,H,sFNa with a molecular weight of 516.41.*

FDA Label Image

Vial 1 (Vial 1)

FDA Label Image

Vial 2 (Vial 2)

This appears to be the label of a medication or medical product called "ckag® B" that must be stored in a sterile environment at a controlled temperature. The recommended dosage information is not present and must be found on a separate insert. The product should be protected from heat and should not be used if a precipitate is present.*

FDA Label Image

Vial 3 (Vial 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.